Sugi Predict

Sugi Predict / Compounds / SCHEMBL2478632

SCHEMBL2478632

SCHEMBL2478632

CC(C)(C)OC(=O)N1CCC2(CC1)CCN(c1ccc(Br)cc1)C2=O

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 6/20 0.57
▸ USP30 Q70CQ3 1/20 0.56
▸ ROCK2 O75116 1/20 0.46
▸ RORC P51449 3/20 0.45
▸ ITGB3 P05106 3/20 0.42
▸ ITGA2B P08514 3/20 0.42
▸ ESRRB O95718 1/20 0.42
▸ ESR1 P03372 1/20 0.42
▸ ESRRA P11474 1/20 0.42
▸ ESRRG P62508 1/20 0.42
▸ FPR2 P25090 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ GPR119 Q8TDV5 1/20 0.42
▸ FPR3 P25089 1/20 0.42
▸ LIPE Q05469 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2470605 0.94 HRH3 (0.60) HRH3USP30ROCK2RORCESRRB
SCHEMBL22396319 0.93 USP30 (0.66) HRH3USP30ROCK2RORCITGB3
SCHEMBL22396214 0.86 USP30 (0.66) HRH3USP30ROCK2ALDH1A1GPR119
SCHEMBL17760752 0.85 USP30 (0.56) HRH3USP30ALDH1A1GPR119
SCHEMBL21753327 0.85 HRH3 (0.55) HRH3USP30ITGB3ITGA2BALDH1A1
SCHEMBL17925123 0.85 GPR119 (0.57) HRH3USP30GPR119
SCHEMBL23529148 0.83 USP30 (0.55) HRH3USP30ROCK2GPR119
SCHEMBL2475109 0.83 HRH3 (0.53) HRH3USP30RORCLMNAGPR119
SCHEMBL30327640 0.82 USP30 (0.53) HRH3USP30ITGB3ITGA2BALDH1A1
SCHEMBL2474190 0.82 HRH3 (0.64) HRH3USP30RORCGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111278825-B Diazaspiro ROCK inhibitors 百时美施贵宝公司 2023-05-02 — — CN disclosed
EP-3704121-B1 DIAZASPIRO ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2022-12-21 — — EP disclosed
EP-3704121-B1 DIAZASPIRO ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2022-12-21 — — EP disclosed
US-11192891-B2 Diazaspiro ROCK inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2021-12-07 — — US disclosed
US-20210188848-A1 DIAZASPIRO ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2021-06-24 — — US disclosed
CN-111278825-A Diazaspiro ROCK inhibitors 百时美施贵宝公司 2020-06-12 — — CN disclosed
US-8604046-B2 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof SANOFI (FR) 2013-12-10 — — US disclosed
EP-2373652-B1 SUBSTITUTED PIPERIDINE SPIRO PYRROLIDINONE AND PIPERIDINONES USED AS H3 MODULATORS SANOFI SA (FR) 2013-10-09 — — EP disclosed
EP-2373652-B1 SUBSTITUTED PIPERIDINE SPIRO PYRROLIDINONE AND PIPERIDINONES USED AS H3 MODULATORS SANOFI SA (FR) 2013-10-09 — — EP disclosed
US-20120258979-A1 SUBSTITUTED PIPERIDINE SPIRO PYRROLIDINONE AND PIPERIDINONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-10-11 — — US disclosed
US-20120258979-A1 SUBSTITUTED PIPERIDINE SPIRO PYRROLIDINONE AND PIPERIDINONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-10-11 — — US disclosed
US-8227481-B2 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof SANOFI (FR) 2012-07-24 — — US disclosed
US-8227481-B2 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof SANOFI (FR) 2012-07-24 — — US disclosed
US-8227481-B2 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof SANOFI (FR) 2012-07-24 — — US disclosed
US-20110257213-A1 SUBSTITUTED PIPERIDINE SPIRO PYRROLIDINONE AND PIPERIDINONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI (FR) 2011-10-20 — — US disclosed
US-20110257213-A1 SUBSTITUTED PIPERIDINE SPIRO PYRROLIDINONE AND PIPERIDINONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI (FR) 2011-10-20 — — US disclosed
US-20110257213-A1 SUBSTITUTED PIPERIDINE SPIRO PYRROLIDINONE AND PIPERIDINONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI (FR) 2011-10-20 — — US disclosed
EP-2373652-A1 SUBSTITUTED PIPERIDINE SPIRO PYRROLIDINONE AND PIPERIDINONES USED AS H3 MODULATORS SANOFI (FR) 2011-10-12 — — EP disclosed
WO-2010065803-A1 SUBSTITUTED PIPERIDINE SPIRO PYRROLIDINONE AND PIPERIDINONES USED AS H3 MODULATORS SANOFI-AVENTIS (FR) 2010-06-10 — — WO disclosed
WO-2010065803-A1 SUBSTITUTED PIPERIDINE SPIRO PYRROLIDINONE AND PIPERIDINONES USED AS H3 MODULATORS SANOFI-AVENTIS (FR) 2010-06-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257213-A1 SUBSTITUTED PIPERIDINE SPIRO PYRROLIDINONE AND PIPERIDINONE, PREPARATION AND THERAPEUTIC USE THEREOF HRH3, HRH4, PRLHR HRH3 1/4885USP30 4428/4885ROCK2 3273/4885
US-11192891-B2 Diazaspiro ROCK inhibitors ROCK1, MYLK, ROCK2 HRH3 2911/4885USP30 2116/4885ROCK2 3/4885
US-20120258979-A1 SUBSTITUTED PIPERIDINE SPIRO PYRROLIDINONE AND PIPERIDINONE, PREPARATION AND THERAPEUTIC USE THEREOF HRH3, HRH4, PRLHR HRH3 1/4885USP30 4428/4885ROCK2 3273/4885
US-20210188848-A1 DIAZASPIRO ROCK INHIBITORS ROCK1, MYLK, ROCK2 HRH3 2911/4885USP30 2116/4885ROCK2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.